The beneficial effect of blood transfusions on renal allografts disapp
eared at about the same time when hepatitis B vaccination was introduc
ed in dialysis patients. To determine possible immunosuppressive effec
ts of hepatitis B vaccination, we studied alloreactivity during the co
urse of immunization. Fourteen healthy subjects without serological ev
idence of hepatitis B were routinely immunized against hepatitis B sur
face antigen. Plasma and mononuclear cells were isolated and frozen be
fore immunization and after vaccination, respectively. Mean alloreacti
vity measured by [H-3]thymidine uptake decreased from 64,772 cpm befor
e immunization to 40,213 cpm after the third immunization. In crossove
r experiments, cellular modulation and plasma-dependent modulation of
alloreactivity were observed. The immunosuppressive effect of plasma t
aken 4 weeks after the third vaccination correlated (r=0.9) highly sig
nificantly (P<0.005) with the anti-hepatitis B surface antigen antibod
y titer. Taken together, our data strongly suggest that hepatitis B va
ccination is capable of reducing allogenic reactivity.